Llwytho...
A meta-analysis comparing regorafenib with TAS-102 for treating refractory metastatic colorectal cancer
OBJECTIVE: We performed this meta-analysis to compare the efficacy and toxicity of regorafenib and TAS-102. METHODS: Electronic databases were searched to identify studies comparing the efficacy and safety of regorafenib and TAS-102 in patients with chemotherapy-refractory metastatic colorectal canc...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | J Int Med Res |
|---|---|
| Prif Awduron: | , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
SAGE Publications
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7361493/ https://ncbi.nlm.nih.gov/pubmed/32660291 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0300060520926408 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|